Outcome of older myeloma patients in relationship to comorbidities and availability of second‐generation novel agents in a real‐life setting
Sign Up to like & getrecommendations! Published in 2022 at "Hematological Oncology"
DOI: 10.1002/hon.3024
Abstract: Major improvements in outcome of older patients with multiple myeloma (MM) have been achieved with the introduction of novel agents. Their impact in real‐life treatment of older patients is unclear. In this single center retrospective… read more here.
Keywords: second generation; real life; novel; outcome older ... See more keywords
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study
Sign Up to like & getrecommendations! Published in 2020 at "Leukemia"
DOI: 10.1038/s41375-020-0758-4
Abstract: Data on outcome in older (≥70 years) patients with acute promyelocytic leukemia after treatment with arsenic trioxide (ATO) compared with standard chemotherapy (CTX) is scarce. We evaluated 433 patients (median age, 73.4 years) treated either… read more here.
Keywords: atra ctx; ctx; ato atra; outcome older ... See more keywords
Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation?
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2020.1715207
Abstract: ABSTRACT Introduction: The clinical outcome of older patients with acute myeloid leukemia (AML) is still poor, especially for those who are unfit to treatments aimed at altering the natural course of the disease. Hypomethylating agents… read more here.
Keywords: hematology; myeloid leukemia; cell transplantation; stem cell ... See more keywords